Showing results (81-90 of 102) with videos related to
Sort By:
Pageof 11
International Journal of Oncology|September 18, 2004
CRIPTO-1: a novel target for therapeutic intervention in human carcinomaNicola Normanno, Antonella De Luca, Monica R Maiello, et al.Proceedings of the National Academy of Sciences of the United States of America|April 30, 2005
Immunomodulatory oligonucleotides containing a cytosine-phosphate-2'-deoxy-7-deazaguanosine motif as potent toll-like receptor 9 agonistsEkambar R Kandimalla, Lakshmi Bhagat, Yukui Li, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 12, 2009
A novel toll-like receptor 9 agonist cooperates with trastuzumab in trastuzumab-resistant breast tumors through multiple mechanisms of actionVincenzo Damiano, Sonia Garofalo, Roberta Rosa, et al.Oncogene|September 21, 2004
Loss of XIAP protein expression by RNAi and antisense approaches sensitizes cancer cells to functionally diverse chemotherapeuticsDan C McManus, Charles A Lefebvre, Gabriele Cherton-Horvat, et al.Organic & Biomolecular Chemistry|January 8, 2013
Design of synthetic oligoribonucleotide-based agonists of Toll-like receptor 3 and their immune response profiles in vitro and in vivoTao Lan, Daqing Wang, Lakshmi Bhagat, et al.FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|November 25, 2021
Suppression of Kv3.3 channels by antisense oligonucleotides reverses biochemical effects and motor impairment in spinocerebellar ataxia type 13 miceYalan Zhang, Imran H Quraishi, Heather McClure, et al.Proceedings of the National Academy of Sciences of the United States of America|November 12, 2003
A dinucleotide motif in oligonucleotides shows potent immunomodulatory activity and overrides species-specific recognition observed with CpG motifEkambar R Kandimalla, Lakshmi Bhagat, Fu-Gang Zhu, et al.Cellular Immunology|May 17, 2011
Synthesis and immunological activities of novel Toll-like receptor 7 and 8 agonistsEkambar R Kandimalla, Mary Struthers, Andrew J Bett, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|July 23, 2009
Coadministration of telomerase genetic vaccine and a novel TLR9 agonist in nonhuman primatesSridhar Dharmapuri, Daniela Peruzzi, Carmela Mennuni, et al.Journal of Medicinal Chemistry|April 7, 2011
Novel oligonucleotides containing two 3'-ends complementary to target mRNA show optimal gene-silencing activityLakshmi Bhagat, Mallikarjuna Reddy Putta, Daqing Wang, et al.Pageof 11